Suzhou Xilin · ISO 22716:2007 Cosmetics Scope (Cert. 27825-2025GPOC00009R000)

Mid-to-High-End Peptide Skincare OEM / ODM: Bulk Bases & Phased Custom Packaging

Manufactured at Suzhou Xilin Technology Co., Ltd. (苏州汐霖生物科技有限公司)—35–45 minutes from Shanghai Hongqiao with an ISO 22716:2007 certified cosmetic facility (explicitly covering liquid & cream/emulsion eye-care and children’s skincare), a 600 m² Class 10,000-tested cleanroom, and patent-pending AHPX+ transdermal carrier technology (CN120248173A). Structured so growing clinical brands and clinic groups launch prestige formulas without rigid enterprise MOQ traps.

Flexible Commercial Architecture

Solving the Custom Packaging Minimum vs. Fresh Formula Shelf-Life Dilemma

Instead of forcing young or mid-market dermocosmetic brands to pre-fill thousands of aging units on Day 1—or settling for low-active commodity sachets—we tailor commercial structure across four project-scoped tracks.

Four flexible peptide skincare OEM/ODM commercial tracks at Suzhou Xilin Technology Co., Ltd.
Commercial Track Packaging & Batch Structure Best Fit For B2B Buyers Sampling & Project Governance
Track 1: Eligible Stock Case-Lot Trial & Bulk Semi-Finished Base (Kg / Liter) Existing qualified stock in available standard packaging (case-lot evaluation) OR bulk compounded serum/cream/gel bases shipped in sealed 1 kg–25 kg fluorinated/HDPE drums for local destination filling. Dermatology clinics, regional distributors, and growing brands validating texture, sensory feel, and repeat purchase—or bypassing custom-bottle MOQs, packaging import tariffs, and volumetric air freight. No custom R&D fee for eligible in-stock items; bulk semi-finished bases quoted per kg/liter with batch COA, % INCI breakdown, and 16-section GHS SDS.
Track 2: Buyer-Branded Custom Packaging + Phased Split-Batch Filling Procure custom silk-screened airless pumps, UV-shielded glass droppers, or cartons under a project-agreed packaging run; store unused packaging under agreed clean warehouse terms and fill across scheduled fresh compounding batches. Indie clinical skincare brands launching bespoke private-label presentation without locking working capital into thousands of pre-filled aging units on Day 1. Packaging ownership, warehouse holding window, wastage allowance, and per-run filling minimums are defined transparently in the project quotation; every batch carries its fresh manufacturing date.
Track 3: Pro-Active Carrier Semi-Customization (AHPX+ / True-Assay GHK-Cu / Acid-Peptide Hybrids) Adapt Suzhou Xilin’s validated base architectures with patent-pending AHPX+ chitosan delivery (CN120248173A), verified net-active Copper Tripeptide-1 (avoiding the 0.01% diluted-solution trap), or pH-buffered PHA + niacinamide + hexapeptide complexes. Mid-to-high-end brands benchmarking prestige clinical serums (e.g., multi-peptide + polyhydroxy acid glass-skin serums, 50% Pro-Xylane + peptide eye/face creams, cooling hydrogel masks). Custom bench sampling starts after signing an NNN/NDA if requested and confirming project scope and sampling milestone terms.
Track 4: Bespoke Dual-PhD Co-Development, Accredited Claim Testing & Territory Exclusivity Dedicated custom formulation led by Dr. Yiqiong Ji’s Suzhou Xilin formulation lab with molecular & carrier review by Dr. Libo Du—paired with optional third-party human/instrumental studies (quoted separately) and regulatory dossiers. Established dermocosmetic brands, aesthetic clinic groups, and national CDMO partners filing EU CPNP (PIF/CPSR), UK SCPN, US FDA MoCRA, or Brazil ANVISA registrations. Scoped under a written milestone agreement; SKU or regional exclusivity can be structured around agreed annual volume commitments.

R&D Benchmark Library

Six Validated Peptide, Nano-PDRN, Hydrogel, Capsule Cream & Scalp Base Architectures

Led by Dr. Yiqiong Ji (20+ years in CAS nanomedicine & transdermal delivery) with scientific review by Dr. Libo Du, combining smart carrier dosing, < 0.5 EU/mL Type III Collagen, and zero-syneresis optical hydrogels.

On-Site Facility & R&D Evidence

Inside Suzhou Xilin’s ISO 22716 Cleanroom & Transdermal Peptide Lab

Inspect verified video walkthroughs of our Taicang, Suzhou cosmetic facility, emulsifying reactors, and AHPX+ transdermal delivery study data.

Open Full Video Evidence Library (8 Videos) →
Company & Production Site Documentary2:55

On-Site Documentary · Taicang, Suzhou · 2:55

Suzhou Xilin Biotechnology (苏州汐霖生物科技有限公司): R&D, Cleanroom Production & Founder Profile

Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.

Verification scope:Registered exhibitor & production entity (苏州汐霖生物科技有限公司), R&D lab & 600 m² cleanroom
Jump to timestamp:

Key Verifiable Points & Parameters

  • Entity & Location: 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.), founded in 2021 in Taicang, Suzhou, Jiangsu, China.
  • Founder & R&D Leadership: Dr. Yiqiong Ji (纪艺琼 / Dr. Kee), with 20 years of research experience in nanomedicine and transdermal active-ingredient delivery across the skin barrier.
  • Cleanroom & Equipment: 600 m² of controlled cleanroom production space, laminar flow benches, overhead formulation mixers, stainless-steel cosmetic emulsifying/homogenizing reactors, packaging lines, and warehouse dispatch.
  • Facility Scope: Covers cosmetic formulation R&D, transdermal delivery systems, and ISO 22716 cosmetic GMP production at Suzhou Xilin.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.

Verbatim Audio / Visual Transcript:Narrator: At Taicang Port (太仓港区), an entrepreneur with a research background at the Chinese Academy of Sciences spent 20 years studying how to improve the delivery of active ingredients across the skin barrier. Then came another four years of turning that research into a real business. Title card: How many skin barriers must skincare ingredients penetrate to be fully absorbed? Dr. Yiqiong Ji (纪艺琼, Founder of 苏州汐霖生物科技有限公司 / Suzhou Xilin Biotechnology Co., Ltd.): "My name is Yiqiong Ji. I founded Suzhou Xilin Biotech in Taicang in 2021. My background is nanomedicine delivery research, essentially helping active ingredients work where they are needed. We apply this knowledge to cosmetics, improving skincare active delivery. Our facility includes 600 m² of cleanroom space, ensuring traceability. Brands choose us for our technical capabilities. For a tech-driven team, R&D, production, and market opening are challenges." Partner commentary: "Support, like a well-designed delivery system, works quietly beneath the surface. We want to be a dependable partner to growing businesses. Ms. Ji’s team remains focused on technology and approaches its work with discipline. Through professional and efficient financial services, we help them concentrate on R&D and production. This gives the company greater stability and confidence as it grows." Dr. Yiqiong Ji: "Our goal is to make advanced technology accessible, enabling brands to benefit from high-quality R&D. Quality, reliable performance, and accessible pricing are our focus. Last year, we successfully launched a cream featuring hydroxypropyl tetrahydropyrantriol (Pro-Xylane) and other products, which were well received. This year we aim to integrate new technologies and ideas for stronger product performance." Partner commentary: "Taicang Port is home to many technology-driven companies like Suzhou Xilin Biotech. They stay focused, develop their expertise, and grow steadily." Dr. Yiqiong Ji: "We are planning our layered Precision Age Care series using a layer-specific skincare approach. It combines our delivery technology with actives to address various signs of aging and skin needs. This multi-level system targets hydration, barrier care, firmness, elasticity, and smoother skin. Each formula addresses a defined concern, reflecting our core principle: precision in formulation design and active ingredient delivery." Narrator: "Research and company building take time, but with sound technology and reliable materials, their value becomes visible."

Editorial & Verification Scope Note:Note on AI English dubbing captions: The video’s burned-in English captions phonetically render 太仓 (Taicang) as "Tai Cheng / Taichung" and 汐霖 (Xilin) as "Silan / Xylan Biotech". The on-screen Chinese signage at 01:04 shows the official registered name: 苏州汐霖生物科技有限公司 (SUZHOU XILIN BIOTECHNOLOGY CO., LTD).

On-Site Exhibition & QC Record1:39

140th Canton Fair · Booth 1.1L14 · 1:39

140th Canton Fair On-Site Record (Booth 1.1L14): Verifiable COA, HPLC/MS & Buyer Discussions

On-site documentary record from Booth 1.1L14 (Area A, Hall 1.1 — New Materials and Chemical Products) at the 140th China Import and Export Fair (Canton Fair) in Guangzhou. Shows real technical consultations with international buyers, framed ISO 22716:2007 certification held by Suzhou Xilin Technology Co., Ltd. (cosmetics scope), framed Janoshik third-party GHK-Cu sample analysis report, Shanghai Weiyu Testing (CNAS L12786 + CMA) cleanroom inspection reports, and our printed Peptide Product Reference catalog.

Verification scope:On-site Booth 1.1L14 exhibition activity, framed ISO 22716 certificate (cosmetics scope), Janoshik sample report & Shanghai Weiyu cleanroom test reports
Jump to timestamp:

Key Verifiable Points & Parameters

  • Exhibition & Location: 140th Canton Fair Phase 1 (15–19 October 2026), Area A, Hall 1.1 (New Materials and Chemical Products), Booth 1.1L14, Guangzhou.
  • Registered Exhibitor & Brand: Exhibited under Suzhou Xilin Technology Co., Ltd. (苏州汐霖生物科技有限公司, also translated as Suzhou Xilin Biotechnology Co., Ltd.) with WUMO Peptide branding and technical team on site.
  • Physical Documentation Displayed: Framed ISO 22716:2007 certificate (cosmetic finished-goods GMP scope, Cert. 27825-2025GPOC00009R000), framed Janoshik third-party GHK-Cu sample analysis report, framed Shanghai Weiyu Testing Technology Co., Ltd. (上海微煜检测技术有限公司, CNAS L12786 + CMA, Report 2025CS-10-1000013) cleanroom inspection reports, and batch-matched COA/HPLC/MS binders.
  • Evidence & Analytical Scope: On-site video confirms trade-fair presence and displayed reference files; batch quality for any order is verified per quoted SKU and lot via agreed COA, RP-HPLC, and LC-MS documentation.
Read Verbatim Transcript, Summary & Verification Scope

Summary:On-site documentary record from Booth 1.1L14 (Area A, Hall 1.1 — New Materials and Chemical Products) at the 140th China Import and Export Fair (Canton Fair) in Guangzhou. Shows real technical consultations with international buyers, framed ISO 22716:2007 certification held by Suzhou Xilin Technology Co., Ltd. (cosmetics scope), framed Janoshik third-party GHK-Cu sample analysis report, Shanghai Weiyu Testing (CNAS L12786 + CMA) cleanroom inspection reports, and our printed Peptide Product Reference catalog.

Verbatim Audio / Visual Transcript:The 140th Canton Fair is done. Five days in Area A, Hall 1.1 — New Materials and Chemical Products. 50,000+ visitors. 1,000+ conversations that started with a peptide name, a sequence, or a supplier COA somebody wasn’t happy with. To everyone who stopped by: thank you. And to the ones who asked the hard questions about purity, methods, and batch matching: those were our favorite conversations, because that question is the one that matters — "Can I verify what I’m buying?" Yes. Real scientists, real factory, both verifiable. Every batch tested by HPLC and Mass Spectrometry, every COA numbered to the actual batch, third-party retests welcome.

Editorial & Verification Scope Note:Editorial & Verification Scope Note: The transcript above is the verbatim voiceover from the original video. The opening voiceover phrases ("50,000+ visitors" and "1,000+ conversations") are general promotional narration in the original video and are not an audited booth headcount or verified statistical count. The voiceover statement ("every batch tested by HPLC and Mass Spectrometry") applies to batches supplied with batch-matched analytical documentation under agreed specifications; buyers should confirm the exact lot-specific test scope (COA, RP-HPLC, LC-MS, and where applicable sterility/endotoxin) for their quoted SKU before ordering. The ISO 22716:2007 certificate shown at 0:44 covers cosmetic finished goods at Suzhou Xilin Technology Co., Ltd. and does not extend to research-peptide synthesis, lyophilization, or pharmaceutical GMP.

Carrier Delivery & Formulation Brief1:20

Delivery System Brief · Acetyl Hexapeptide-8 · 1:20

AHPX+ (Acetyl Hexapeptide-8 + Hydrolyzed Chitosan Carrier): Penetration & 28-Day Split-Face Study

Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).

Verification scope:Hydrolyzed chitosan peptide delivery concept (CN120248173A), preclinical penetration & GQI 28-day split-face data
Jump to timestamp:

Key Verifiable Points & Parameters

  • Delivery Architecture: Pairs Acetyl Hexapeptide-8 with a patent-pending hydrolyzed chitosan carrier (CN120248173A) designed to improve hydrophilic peptide transport across the stratum corneum.
  • Preclinical Fluorescence Penetration (Mouse Skin Model): Carrier formula showed +82% higher relative fluorescence at 2 hours and +219% (3.19×) higher at 8 hours compared with Acetyl Hexapeptide-8 alone.
  • 28-Day Split-Face Study Design (GQI, n = 33): 33 adult volunteers comparing a cream containing 1% AHPX+ against a comparator cream from Day 0 to Day 28.
  • Measured Day 28 Split-Face Outcomes: Crow’s-feet volume decreased by 38.49%, length decreased by 30.4%, and the Cutometer R2 gross elasticity parameter increased by 17.46% (~17.6% rounded in video) vs baseline on the 1% AHPX+ side.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).

Verbatim Audio / Visual Transcript:Meet AHPX+, a cosmetic ingredient system built around Acetyl Hexapeptide-8. Computational screening helped guide peptide selection. The selected peptide is paired with a hydrolyzed chitosan carrier. In a mouse skin model, the carrier formula showed higher relative fluorescence than the peptide alone at 2 and 8 hours (+82% at 2 h and +219% at 8 h vs peptide alone; supplier-reported preclinical data). Laboratory assays also explored the peptide’s molecular interactions. The supplier then conducted a 28-day half-face study with 33 adults comparing a cream containing 1% AHPX+ with a comparator cream. At day 28, measured crow’s-feet length fell 30.4%, while the R2 elasticity parameter rose 17.6% from baseline on the AHPX+ side. Explore AHPX+ for skincare designed to improve the appearance of fine lines and firmness. For cosmetic formulation development.

Editorial & Verification Scope Note:Preclinical fluorescence penetration and 28-day split-face figures reflect data for the tested 1% AHPX+ carrier formulation (n = 33, Guangzhou Quality Supervision & Testing Institute). Confirm whether your inquiry requires neat Acetyl Hexapeptide-8 powder (CAS 616204-22-9) or the 1,000 ppm AHPX+ carrier complex when requesting specifications and samples.

Scalp Care Active Brief1:05

Scalp-Care Formulation Brief · 1:05

Menthol Citrate Ester: Amphiphilic Scalp-Care Active Dispersion & In-Vitro Study Overview

Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.

Verification scope:Scalp-care co-formulation active, aqueous dispersion & supplier in-vitro test summary
Jump to timestamp:

Key Verifiable Points & Parameters

  • Chemistry & Structure: Synthesized via esterification of L-menthol with citric acid, combining a cooling menthol sensory profile with an amphiphilic structure.
  • Formulation Compatibility: Disperses more readily than free menthol in water-based and multi-phase scalp systems, including shampoos, scalp cleansing gels, and leave-on scalp sprays.
  • Supplier In-Vitro Contact Data (3-Minute Contact): A tested shampoo containing 1.5% to 2.0% Menthol Citrate Ester showed 90.59% (at 1.5%) to 95.29% (at 2.0%) inhibition of Malassezia furfur in laboratory testing.
  • Scalp-Care Co-Formulation Context: Evaluated alongside scalp-care actives such as Diaminopyrimidine Oxide (Aminexil) and Copper Tripeptide-1 (GHK-Cu) in OEM/ODM hair and scalp programs.
Read Verbatim Transcript, Summary & Verification Scope

Summary:Formulation overview of Menthol Citrate Ester — a cooling scalp-care active synthesized by esterifying L-menthol with citric acid. Explains its amphiphilic dispersion in aqueous and multi-phase scalp formulas (shampoos, scalp cleansing gels, scalp sprays) and supplier in-vitro contact testing against Malassezia furfur at 1.5%–2.0%.

Verbatim Audio / Visual Transcript:A refreshing scalp care formula starts with the right ingredient. Menthol citrate ester is made by esterifying L-menthol with citric acid. It retains a fresh menthol sensation. Its amphiphilic structure helps it disperse in water-based and multi-phase formulations. Formulators can explore it in shampoos, scalp cleansing gels, and scalp sprays. In supplier laboratory testing, a shampoo with 1.5% to 2.0% menthol citrate ester showed 90.59% to 95.29% inhibition of Malassezia furfur after 3 minutes of contact (supplier-reported in-vitro data for the tested formula). Bring a clean cooling sensation to your next scalp care concept with menthol citrate ester. For cosmetic formulation development.

Editorial & Verification Scope Note:Menthol Citrate Ester is a non-peptide cosmetic scalp-care functional ester supported in WUMO / Suzhou Xilin scalp formulation programs. In-vitro Malassezia furfur inhibition figures apply only to the supplier-tested shampoo formula under 3-minute laboratory contact conditions and do not constitute an anti-dandruff drug or medical claim.

Export Regulatory & Commercial Governance

EU / UK / US / Brazil Cosmetic Filing Support & B2B Commercial Governance

Clear division of manufacturer technical documentation, confidential IP protection (NNN / NDA), and corporate settlement.

Export Technical Dossier (PIF / CPSR / CPNP / MoCRA / ANVISA Support)

  • ISO 22716:2007 Cosmetics GMP Certificate (27825-2025GPOC00009R000): Held by manufacturing entity Suzhou Xilin Technology Co., Ltd. (valid 2025-10-20 to 2028-10-19, covering general liquid and cream/emulsion skincare including eye-care and children’s skincare; open PDF certificate). Strictly covers finished cosmetic manufacturing only.
  • Quantitative % w/w INCI Formula Breakdown: Exact CAS & INCI composition bands, raw-material SDS/COA annexes, and allergen declarations supplied under NDA/NNN to your designated Safety Assessor for CPSR & Product Information File (PIF) compilation.
  • Finished Batch Release Pack: Lot-specific COA (total aerobic microbial count, yeast/mold, specified pathogens, heavy metals Pb/As/Hg/Cd, pH, viscosity, organoleptic check) + 16-section English GHS SDS for sea/air freight and 3PL intake.
  • Scope Note: Final portal notification under EU CPNP, UK SCPN, US FDA MoCRA, or Brazil ANVISA is filed by the buyer’s local Responsible Person / U.S. Agent using our manufacturer dossier; external clinical or challenge tests are scoped and quoted per project.

Commercial Settlement & IP Protection (NNN / NDA)

Confidential Custom Formulation & Corporate Wire Settlement

WUMO partners directly with registered cosmetic brands, dermatology/aesthetic clinic groups, regional distributors, and licensed importers under structured B2B project governance:

  • Mutual NNN / NDA Protection: Custom formulation briefs, quantitative INCI breakdowns, and proprietary active ratios are protected under mutual NNN/NDA agreements prior to bench sampling.
  • Official Domain Correspondence: All formal quotations, sample milestone confirmations, and proforma invoices are issued directly from verified @wumolab.com account managers.
  • Corporate Bank Wire Settlement (T/T): Commercial orders settle via corporate bank wire transfer (T/T) to our verified Hong Kong or Mainland China corporate accounts specified on the signed Proforma Invoice.

Frequently Asked Questions

How do growing skincare brands and clinics avoid crushing upfront MOQs in custom peptide ODM?

Rather than publishing rigid one-size-fits-all MOQ walls or cutting active levels down to commodity white-label quality, Suzhou Xilin (ISO 22716:2007) offers four project-scoped routes: (1) case-lot evaluation on eligible stocked items or bulk semi-finished serum/cream/mist bases supplied by the kilogram/liter for local filling; (2) buyer-branded custom packaging paired with agreed phased split-batch filling runs so unused packaging stays under clean storage terms while each filled batch carries a fresh production date; (3) AHPX+ / true-assay GHK-Cu semi-customization; and (4) bespoke Dual-PhD co-development.

How are benchmark samples and custom R&D formulation bench trials structured?

Eligible stocked reference formulas can be evaluated rapidly by qualified B2B corporate buyers, while custom-engineered peptide formulations (custom active %, AHPX+ carrier integration, PHA/niacinamide pH buffering, or custom sensory tuning) proceed under an NNN/NDA if requested and transparent project-agreed sampling milestone terms.

Can you provide documentation to support EU/UK PIF, CPSR, CPNP, US MoCRA, and Brazil ANVISA filings?

Yes. Suzhou Xilin Technology Co., Ltd. holds ISO 22716:2007 Cosmetics GMP certification (Certificate No. 27825-2025GPOC00009R000, covering general liquid and cream/emulsion skincare including eye-care and children’s skincare) and provides the manufacturer technical dossier under NDA: exact % w/w INCI quantitative breakdown, raw-material COAs/SDS/allergen declarations, finished-batch COA (microbiology, heavy metals, pH, viscosity), and 16-section English GHS SDS. Final CPNP/SCPN/MoCRA/ANVISA portal submission remains under the brand owner’s designated Responsible Person or U.S. Agent.

How are commercial settlement and confidential formulation IP (NNN / NDA) handled for B2B OEM orders?

WUMO serves registered B2B corporate buyers, clinical skincare brands, and dermatology/aesthetic groups. Mutual NNN/NDA agreements are available prior to custom bench formulation, and all official quotations and proforma invoices settle via corporate bank wire (T/T) to verified Hong Kong or Mainland China corporate accounts confirmed through @wumolab.com correspondence.

Start Your Peptide Skincare OEM, Bulk Base, or Split-Batch ODM Brief

Share your target product format (serum, eye/face cream, soothing mist, hydrogel mask, or scalp tonic), hero peptide active, packaging direction (bulk kg/L drum vs. custom bottles), and destination market.

Finished Peptide Skincare OEM / Bulk Base / Phased ODM Quotation

Tell us whether you want eligible stock evaluation, bulk semi-finished bases (kg/liter), or buyer-branded custom packaging with phased split-batch filling.

If the embedded form does not load, email [email protected] with your brand website and project brief.

Email Instead